Sophisticated implantable medical device for urinary and bowel dysfunction leverages Aptar’s groundbreaking 3-Phase Activ-Polymer™ technology to control moisture and extend use life.
Aptar CSP Technologies, a leader in active material science solutions (part of AptarGroup, Inc.), announced that its proprietary Activ-Film™ technology was approved by the U.S. Food and Drug Administration (FDA) for use within a recently launched Rechargeable Implantable Neurostimulator (INS) that treats urinary and bowel dysfunction. The Activ-Film™ material is integrated into the medical device to control humidity, improve the accuracy of readings, and extend use life.
Aptar CSP’s Activ-Film™ material leverages the company’s patented 3-Phase Activ-Polymer™ platform technology to manage the device’s internal atmosphere, adsorbing moisture that could otherwise accumulate and affect the implant’s stability and performance. Controlling the humidity within the device protects the battery and enables it to have little to no degradation during its use life.
“This is another example of our consistent commitment to helping customers bring advanced solutions to patients and improve user experiences and outcomes,” said Badre Hammond, Vice President Commercial Operations, Aptar CSP Technologies. “We are dedicated to continued material science innovation that facilitates the development and commercialization of next generation implantable medical devices.”
Activ-Film™ material is a configuration of Aptar CSP’s 3-Phase Activ-Polymer™ technology. In addition to protecting a range of implantable medical devices, the highly-engineered technology is utilized in various formats for a broad array of applications, including oral solid dose drugs, drug delivery systems and probiotics. The material science technology can be customized to deliver integrated active solutions that adsorb moisture, scavenge oxygen, odor, or VOCs, emit aromas, or reduce pathogens.
About Aptar
Aptar CSP Technologies is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective packaging technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.
Aptar CSP Technologies is the premier active material science solutions expert that transforms ideas into market opportunities, accelerates and de-risks the product development process, and provides complete solutions that improve consumers’ and patients’ lives. Providing innovative, highly-engineered material science and active packaging solutions to protect sensitive products, Aptar CSP Technologies is a responsive, flexible partner committed to offering customers a single, reliable source for custom product design, development, and manufacturing. For more information, visit www.csptechnologies.com.
